Avast Therapeutics
PrivateCompany Overview
Avast Therapeutics operates in Healthcare & Life Sciences and is based in Lexington, Kentucky. It was founded in 2016.
Avast Therapeutics is a biopharmaceutical company developing non-invasive, blood-brain barrier-penetrating peptide therapeutics to treat neurodegenerative diseases such as Parkinson's and Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avast Therapeutics Comparables
Compare Avast Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhittya Genesis Medicine | 84% | |
| Lucy Therapeutics | 79% | |
| Gismo Therapeutics | 78% |
For institutional investors. Book with your work email.
Avast Therapeutics Funding Rounds
Historical fundraising activity
Avast Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avast Therapeutics's valuation, stock price, and market status.
Is Avast Therapeutics a public or private company?
Avast Therapeutics is a private company.
What is the current stock price of Avast Therapeutics?
Avast Therapeutics is a private company, so its shares have no public market price. Caplight tracks Avast Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avast Therapeutics worth (valuation)?
Valuation information for Avast Therapeutics is not publicly available.
Can I buy Avast Therapeutics stock?
Avast Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avast Therapeutics's last funding round?
Funding round information for Avast Therapeutics is not publicly available.
Who are the main investors in Avast Therapeutics?
Investor information for Avast Therapeutics is not publicly disclosed.
Will Avast Therapeutics IPO soon?
No public IPO plans have been announced for Avast Therapeutics.
How can I track Avast Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Avast Therapeutics's shares on secondary markets.